Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer’s Bid May Have Been Invited by U.K.’s Tax Policy
Bloomberg
Tuesday, April 29, 2014 - 8:27am
tags:
Pfizer, M&A, UK, taxes, AstraZeneca
Actavis sues U.S. drug regulator over generic Celebrex
Yahoo/Reuters
Tuesday, April 29, 2014 - 8:27am
tags:
Actavis, generics, Pfizer, Celebrex, patents, FDA, Teva Pharmaceuticals, Mylan
Sanofi CEO says focusing on smaller, 'bolt-on' deals, WSJ reports
Yahoo/Fly on the Wall
Tuesday, April 29, 2014 - 8:25am
tags:
Sanofi, Pharma CEOs, M&A, Chris Viehbacher
Wockhardt in Talks to Sell India Drugs Business, ET Now Reports
Bloomberg
Tuesday, April 29, 2014 - 8:25am
tags:
Wockhardt, India, M&A
Bristol-Myers quarterly profit beats expectations as costs cut
Yahoo/Reuters
Tuesday, April 29, 2014 - 8:11am
tags:
Bristol-Myers Squibb, earnings
Bristol-Myers Squibb Acquires iPierian, Inc.
Yahoo
Tuesday, April 29, 2014 - 8:10am
tags:
iPierian, Bristol-Myers Squibb, M&A, IPN007
Merck 1st-quarter profit tops estimate, but revenue misses
CNBC
Tuesday, April 29, 2014 - 8:07am
tags:
earnings, Merck
Reforming The FDA Can Save $900 Million Annually And Generate $4 Trillion In Annual Social Value
Forbes
Tuesday, April 29, 2014 - 7:45am
tags:
FDA
Amicus Therapeutics fat disorder drug effective in trial
Yahoo/Reuters
Tuesday, April 29, 2014 - 7:37am
tags:
Amicus Therapeutics, Migalastat HCl, Fabry's disease
Irreconcilable differences? Allergan investors wary of suitor Valeant's cost-slashing style
Fierce Pharma
Monday, April 28, 2014 - 5:56pm
tags:
Allergan, Valeant Pharmaceuticals
Will Boston Scientific (BSX) Beat Earnings This Quarter?
Yahoo/Zacks.com
Monday, April 28, 2014 - 5:54pm
tags:
earnings, Boston Scientific, devices
Will Bristol-Myers (BMY) Beat Q1 Earnings?
Yahoo/Zacks.com
Monday, April 28, 2014 - 5:52pm
tags:
earnings, Bristol-Myers Squibb
AstraZeneca Gives Pfizer the Cold Shoulder
Wall St Cheat Sheet
Monday, April 28, 2014 - 5:49pm
tags:
Pfizer, AstraZeneca, M&A
Allergan likely to receive higher bid from Valeant, says Sterne Agee
Yahoo/Fly on the Wall
Monday, April 28, 2014 - 12:33pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Reckitt Benckiser confirms talks to buy Merck unit
Yahoo/Reuters
Monday, April 28, 2014 - 12:31pm
tags:
Merck, M&A, Reckitt Benckiser, consumer health
Reckitt and Bayer circle Merck auction of consumer healthcare
FT.com
Monday, April 28, 2014 - 12:12pm
tags:
Bayer, Reckitt Benckiser, consumer healthcare, Merck, M&A
Sanofi Dengue Vaccine Succeeds in Reducing Disease, Study Shows
Bloomberg
Monday, April 28, 2014 - 10:48am
tags:
vaccines, Sanofi, dengue
FDA okays start of BrainStorm stem cell trial in ALS patients
Yahoo/Reuters
Monday, April 28, 2014 - 10:47am
tags:
FDA, stem cells, ALS, clinical trials, BrainStorm Cell Therapeutics
FDA Banned Drug Plant After Finding Data Flaws, Rat Traps
Bloomberg
Monday, April 28, 2014 - 10:44am
tags:
FDA, Sun Pharma, India
Why pay $100B for AstraZeneca? Let Pfizer's CEO count the reasons
Fierce Pharma
Monday, April 28, 2014 - 10:38am
tags:
M&A, Pharma CEOs, Pfizer, AstraZeneca, Ian Read

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.